US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 19.780
  • -0.980-4.72%
Close Nov 11 16:00 ET
  • 19.700
  • -0.080-0.40%
Post 18:55 ET
502.71MMarket Cap-428P/E (TTM)

Cartesian Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 8, 2024

Based on 6 analysts giving stock ratings to Cartesian Therapeutics in the past 3 months

Strong Buy

  • Buy

    83.33%

  • Hold

    16.67%

  • Sell

    0.00%

Price Target

Updated: Nov 8, 2024

The average Cartesian Therapeutics stock price target is 40.25 with a max estimate of 41.00 and a min estimate of 39.00

Review Cartesian Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 8, 2024

Strong Buy

  • Buy

    83.33%

  • Hold

    16.67%

  • Sell

    0.00%

Price Target

Updated: Nov 8, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data